Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Quarterly results
TETRAPHASE PHARMACEUTICALS INC (TTPH) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/31/2020 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
08/31/2020 EFFECT Form EFFECT - Notice of Effectiveness:
08/31/2020 EFFECT Form EFFECT - Notice of Effectiveness:
08/31/2020 EFFECT Form EFFECT - Notice of Effectiveness:
08/24/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/24/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/24/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/24/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/24/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/24/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/24/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/24/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/24/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/24/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
08/24/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
08/24/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
08/24/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
08/24/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
08/11/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
08/07/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
07/30/2020 4 ARMISTICE CAPITAL, LLC (10% Owner) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC
Txns: Disposed of 1,419,507 shares @ $0
Disposed of 1,430,493 options to buy @ $0.01, valued at $14.3k
Disposed of options to buy @ $0.01, valued at $0
Disposed of 2,063,334 options to buy @ $0.001, valued at $2.1k
Disposed of options to buy @ $0.001, valued at $0
Disposed of 2,130,493 warrants @ $3.62, valued at $7.7M
Disposed of warrants @ $3.62, valued at $0
Disposed of 3,333,334 warrants @ $2.87, valued at $9.6M
Disposed of warrants @ $2.87, valued at $0
07/30/2020 SC 13D/A ARMISTICE CAPITAL, LLC reports a 0% stake in Tetraphase Pharmaceuticals, Inc.
07/29/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/29/2020 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/29/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/29/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/29/2020 4 Macdonald Guy (Director) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC
Txns: Unknown transaction of 15,703 shares @ $0
07/29/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/29/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/29/2020 8-K Quarterly results
07/28/2020 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
07/28/2020 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
07/28/2020 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
07/28/2020 GN La Jolla Pharmaceutical Company Announces the Closing of Acquisition of Tetraphase Pharmaceuticals, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy